A Dose-finding Study of Silodosin in Patients With Urinary Calculi

NCT01539265 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2013-10-30

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and the safety of silodosin in urinary calculi patients.

Conditions

  • Urinary Calculus

Interventions

DRUG

silodosin

DRUG

silodosin

DRUG

placebo

Sponsors & Collaborators

  • Kissei Pharmaceutical Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Tatsuro Takei · Clinical Development Department, Kissei pharmaceutical Co., Ltd.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Japan

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01539265 on ClinicalTrials.gov